晋百慧凯发app官网 -凯发app

genebiohealth co.,ltd(gbh) was founded by dr. haoyang yu, who is the member of the national overseahigh level talent project called the peacock project, on august of 2013 inshenzhen, china, focusing on ivd and healthcare, gbh is now the national hi-techenterprise.


   


gbh now possesses a headquarter in shenzhen as large as 1,500 m2with over 500 m2 gmp standard workshop, a 2,700 m2 manufacturing base inzhongshan with 1,000 m2 gmp standard workshop and also a 1,500 m2 third partyclinical lab called shenzhen huikang clinical laboratory with 1,000 m2 gmpstandard workshop. now comprehensive technology, assay and instrument solutionsin cancer diagnosis, pathogen diagnosis by nucleic acid, human leukocyteantigen typing, poct and automatic detection instruments can be perfectlyprovided by gbh.



currently among all gbhproducts, 3 grade i medical instruments, 9 grade ii medical instruments and 1grade iii medical instruments have been registered and approved and over 34 patents applied.



product list:

  • baihuikang tm hypochlorous acid disinfectant

disinfectant registration no. (2019)-02-9173   intended use: pathogen sterilization, personal and environmental protection.50ml per package. production capacity: 3000pcs/day.

  • sars-cov-2 nucleic acid test kit (pt-pcr)   

intended use: nucleic tests for patients and suspected cases of covid-19.   96 tests per kit. production capacity: 500kits/day. ce approved.

  • influenza a, influenza b, covid-19 nucleic acid typing kit (rt-pcr)

intended use: nucleic acid typing of influenza a, influenza b and covid-19 to identify influenza patients from covid-19 patients or help to diagnose covid-19 patients. 96 tests per kit. production capacity: 500kits/day.

  • automatic microvolume liquid handling system pcready® 9600   

nmpa medical equipment registration no. 20150028 in china. intended use: part of the automatic nucleic acid pcr tests of sars-cov-2 and other pathogens and improving the efficiency and data quality of nucleic test. production capacity: 2 per week.

  • rna extraction kit (cp-009)   

nmpa medical equipment registration no. 20150028 in china. intended use: samples like sars-cov-2 rna extraction. 50 tests/kit. production capacity: 500 kits/day. ce approved.

  • c reaction protein test kit (colloidal gold)

nmpa medical equipment registration no. 20162400256 in china. intended use: regular test for infections of respiratory diseases. 20 tests/kit. production capacity: 2000kit/week.

  • procalcitonin (pct) test kit (colloidal gold)

nmpa medical equipment registration no. 20142400309 in china. intended use: bacterial infection detection. 20 tests/kit. production capacity: 2000kit/week.

  • nt-probnt test kit (colloidal gold)

nmpa medical equipment registration no. 20162400252 in china. intended use: ards and heart failure. 20 tests/kit. production capacity: 2000kit/week.

  • mir-92 assay kit (rt-pcr)

nmpa medical equipment registration no. 20183400108 in china. intended use: assistant diagnosis of early stage colorectal cancer or precancerous lesions. 48 tests/kit. production capacity: 500kit/week. ce approved.

  • feces sample collector

nmpa medical equipment registration no. 20180564 in china. intended use: feces sample collection and transportation. 1 sample/pcs. production capacity:2000pcs/day.

  • ctn1 test kit (colloidal gold)

nmpa medical equipment registration no. 20162400255 in china. intended use: myocardial infarction risk detection. 20 tests/kit. production capacity: 2000kit/week.

  • h-fabp test kit (colloidal gold)

nmpa medical equipment registration no. 20162400251 in china. intended use: myocardial infarction risk detection. 20 tests/kit. production capacity: 2000kit/week.

  • d-dimer test kit (colloidal gold)

nmpa medical equipment registration no. 20162400254 in china. intended use: thrombolysis detection. 20 tests/kit. production capacity: 2000kit/week.

  • immunochromatographicanalyzer

nmpa medical equipment registration no. 2014220310 in china. intended use: generating colloidal gold test results. production capacity: 50/month

  • colloidal gold indicator analyzer

nmpa medical equipment registration no. 20172400255 in china. intended use: generating colloidal gold test results.production capacity: 50/month

  • sars-cov-2 igm igg test kit (colloidal gold)

intended use: covid-19 cases diagnosis or screening. 20 tests/kit. production capacity: 2000kit/week. ce approved.

about us
product
news
lessons
service
telephone:
0755-86573093
shenzhen genebiohealth co., ltd
fax:( 86)755-86573069   e-mail:service   address:buliding a9-2f, tianliao industrial park a, taoyuan street, nanshan district, shenzhen, china
凯发app copyright ©2018 shenzhen genebiohealth co., ltd 凯发app copyright

buy online
follow wechat